Identifying and treating undiagnosed asthma or COPD in Canadians
Official title: Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL
Run by Ottawa Hospital Research Institute · NCT06392776 · Data updated 2026-11-12
This study is trying to find Canadians who might have asthma or COPD without knowing it and see if getting diagnosed and treated early can improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 420 (estimated) |
| Sponsor | Ottawa Hospital Research Institute Academic / other |
| Locations | 6 sites (Hamilton, Ontario and 5 other locations) |
| Status | Recruiting |
| Started | July 16, 2024 |
| Main results expected | December 2028 |
| Study ends | December 2029 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT06392776 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are symptomatic individuals aged 18 and older who score a ≥ 6% probability of having asthma or COPD based on the UCAP-Q questionnaire.
✕Probably not a fit
Patients with a previous diagnosis of asthma, COPD, or other significant lung diseases will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to identify Canadians who may have undiagnosed asthma or chronic obstructive pulmonary disease (COPD) using an online questionnaire developed by the research team. Individuals who score a certain probability of having these conditions will be invited to participate in a randomized controlled trial to assess the impact of early diagnosis and treatment on their quality of life. The study focuses on symptomatic individuals aged 18 and older who can perform lung function tests. The goal is to improve health outcomes for those with previously undiagnosed respiratory conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved quality of life for patients with undiagnosed asthma or COPD through early diagnosis and treatment.
How similar studies have gone: Other studies have shown success in early diagnosis and treatment approaches for respiratory conditions, indicating potential for positive outcomes in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals at least 18 years old * Individuals must be symptomatic with respiratory symptoms * Individuals must complete the UCAP-Q questionnaire and score a ≥ 6% probability of having either asthma or COPD. * Individuals who have given written informed consent to participate in this trial in accordance with local regulations; * Individual must be able to perform pre and post bronchodilator spirometry to measure lung function Additional Inclusion Criteria for the Randomized Controlled Trial (RCT): * Individuals who have undiagnosed airflow obstruction on spirometry testing (i.e. Asthma or COPD) will be asked to participate in the RCT. Exclusion Criteria: * Individuals who report a previous diagnosis of asthma, COPD, history of lung cancer, bronchiectasis, interstitial lung disease, cystic fibrosis or other significant diagnosed lung disease. * Individuals currently under the care of a Respirologist. * Individuals currently using inhaled corticosteroids or long-acting bronchodilators. * Individuals with history of myocardial infarction, stroke, aortic or cerebral aneurysm, or detached retina or eye surgery within the past 3 months (spirometry is contraindicated) * Individuals who are in the third trimester of pregnancy * Individuals involved in another interventional trial
Where it's running
-
St. Joseph's Hamilton Healthcare
Hamilton, Ontario, Canada Recruiting -
Kingston Health Sciences Centre/Queen's University
Kingston, Ontario, Canada Recruiting -
Ottawa Hospital General Campus
Ottawa, Ontario, Canada Recruiting -
St. Michael's Hospital/Unity Health Toronto
Toronto, Ontario, Canada Recruiting -
Institut universitaire de cardiologie et de pneumologie de Québec
Québec, Quebec, Canada Recruiting -
Royal University Hospital
Saskatoon, Saskatchewan, Canada Recruiting
Study contacts
- Principal investigator: Shawn Aaron, MD — Ottawa Hospital Research Institute
- Study coordinator: Shawn Aaron, MD
- Email: saaron@toh.ca
- Phone: 6137378259
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asthma and COPD among workers at Navanakorn Industrial Zone in Thailand
This project will test how common asthma and COPD are among adult workers at the Navanakorn Industrial Zone by asking about breathing symptoms and doing lung function (spirometry) tests.
-
Using oscillometry and FeNO to improve primary care diagnosis of asthma and COPD
This study will test whether oscillometry and FeNO measurements help primary care doctors more accurately diagnose asthma and COPD in adults with suspected symptoms.
-
Using smartphone technology to evaluate airway conditions
This study is testing if smartphone technology can help check lung health and spot breathing problems in both healthy people and those with asthma or COPD.
-
Understanding muscle loss in patients with chronic lung diseases
This study looks at how muscle loss affects people with chronic lung diseases like COPD and ILD to see how common it is and how it relates to their overall health.
-
Understanding immune profiles in healthy and diseased lungs
This study is trying to understand how the immune system works in healthy lungs compared to those with airway diseases like COPD and asthma by looking at samples from both groups.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.